Probiotics for use in expecting female mammals for enhancing the immunity of their offsprings
View Patent ↗The present invention relates to the use of probiotic on expecting female mammals to boost the immune status of offspring. The use can induce an enhanced response of the offspring after birth to an infectious antigenic exposure. Ultimately the use of probiotic in expecting females can induce a better protection of offspring against infectious diseases.
1. A method for improving immunity in an offspring, the method comprising:
administering to a female mammal, for a time period that begins one to two months before fecundation and is more than 50% of the gestation period, a composition comprising an effective amount of a probiotic so as to boost the immunity of the offspring after birth; and
administering an effective amount of the probiotic to the offspring after birth via the female mammal that is lactating, the probiotic comprising Bifidobacterium lactis CNCM I-3446.
2. The method of claim 1 wherein the administering of the composition to the female mammal comprises boosting the innate immune functions and promoting specific immune response to infectious antigens of the offspring.
3. The method of claim 1 wherein the composition reinforces the transmission of immune competences from the females to the offspring.
4. The method of claim 1 wherein the female mammal is human.
5. The method of claim 1 wherein the composition is administered orally to the female.
6. The method of claim 1 wherein the composition is administered to the female mammal daily for all of the gestation period and all of the lactation period of the female.
7. The method of claim 1 wherein the composition comprises ingredients selected from the group consisting of inulin, fructooligosaccharide (FOS), short-chain fructooligosaccharide (short chain FOS), galacto-oligosaccharide (GOS), xylooligosaccharide (XOS), glanglioside, partially hydrolysed guar gum, acacia gum, soybean-gum, Lactowolfberry, wolfberry extracts and mixtures thereof.
8. The method of claim 1 wherein the immunity boost comprises an increase in the ability of the offspring to respond to an antigenic exposure.
9. The method of claim 8 wherein the response to the antigenic exposure comprises an elevation of the specific antibodies to the antigens in the serum, saliva or faeces of said offspring.
10. The method of claim 8 wherein the response to the antigenic exposure comprises an elevation of the total poly-reactive antibodies in the offspring.
11. The method of claim 8 wherein the response to the antigenic exposure comprises an elevation of cellular immune response in the blood of the offspring.
12. The method of claim 8 wherein the antigenic exposure comprises exposure to at least one agent selected from the group consisting of viruses, bacteria, infective parasites infection and mixtures thereof.
13. The method of claim 8 wherein the increased ability to respond to the antigenic exposure contributes to better protect the offspring against infections in early life.
14. The method of claim 1 wherein the immunity boost reaches its maximum during a lactation period, or during a juvenile phase of the offspring.
15. The method of claim 1 wherein the composition is further administered to the offspring during a period selected from the group consisting of lactation, after a full weaning and after a partial weaning.
16. A method for boosting the immunity of an offspring, the method comprising:
administering to a female mammal, for a time period that begins one to two months before fecundation and is more than 50% of the gestation period, a composition comprising a probiotic that is Bifidobacterium lactis CNCM I-3446, the probiotic being present in an amount equivalent to between 10 3 and 10 10 cfu per gram of dry composition.
17. The method of claim 1 wherein the composition is administered in a form selected from the group consisting of food, drinks, dietary supplements and pharmaceutical compositions.
18. The method of claim 1 wherein the immunity boost reaches its maximum between birth (day 0) and day 180 of life.
19. The method of claim 1 wherein the probiotic is present in an amount equivalent to between 10 3 and 10 10 cfu per gram of dry composition.
20. A method for improving immunity to tetanus toxoid vaccination in an offspring, the method comprising:
administering to a female mammal, for a time period that begins one to two months before fecundation and is more than 50% of the gestation period, a composition comprising an effective amount of a probiotic so as to boost the immunity to tetanus toxoid vaccination of the offspring after birth; and
administering an effective amount of the probiotic to the offspring after birth via the lactating mother, the probiotic comprising Bifidobacterium lactis CNCM I-3446.